I was diagnosed with follicular lymphoma grade 1-2. Anyone with the same diagnosis in this team? And what is the difference from grade 1-2 to Stage 1?
November 13, 2025
What are the treatment results and outcomes for rituximab and mosunetuzumab in lymphoma?
Rituximab has become a well-established treatment for various types of lymphoma with proven effectiveness. It's commonly used both as a first-line treatment and for relapsed or refractory cases.
Rituximab Treatment Results:
Rituximab Show Full Answer
What are the treatment results and outcomes for rituximab and mosunetuzumab in lymphoma?
Rituximab has become a well-established treatment for various types of lymphoma with proven effectiveness. It's commonly used both as a first-line treatment and for relapsed or refractory cases.
Rituximab Treatment Results:
Rituximab works by targeting the CD20 protein on B cells, helping the immune system attack and destroy cancer cells. It's approved for multiple lymphoma types including:
- B-cell non-Hodgkin lymphomas
- Diffuse large B-cell lymphoma (often combined in R-CHOP regimen)
- Marginal zone lymphoma
- Follicular lymphoma
- Chronic lymphocytic leukemia/small lymphocytic lymphoma
Rituximab can be given alone (monotherapy) or combined with chemotherapy drugs. Many doctors prefer rituximab because it's less toxic and causes fewer side effects than traditional chemotherapy alone.
The drug has significantly improved quality of life and overall survival for both adults and children with lymphoma when used as part of immunotherapy approaches.
Important Note: The search results don't contain specific information about mosunetuzumab outcomes. You may want to discuss this newer treatment option directly with your oncologist, as they'll have access to the latest clinical trial data and can explain how it might fit into your specific treatment plan.
November 13, 2025
Join
Your Privacy Choices
